0001161697-16-000827.txt : 20160512 0001161697-16-000827.hdr.sgml : 20160512 20160512090024 ACCESSION NUMBER: 0001161697-16-000827 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160512 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160512 DATE AS OF CHANGE: 20160512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VISUALANT INC CENTRAL INDEX KEY: 0001074828 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 911948357 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37479 FILM NUMBER: 161641782 BUSINESS ADDRESS: STREET 1: 500 UNION STREET STREET 2: SUITE 420 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-903-1351 MAIL ADDRESS: STREET 1: 500 UNION STREET STREET 2: SUITE 420 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: Visualant, INC DATE OF NAME CHANGE: 20050106 FORMER COMPANY: FORMER CONFORMED NAME: STARBERRYS CORP DATE OF NAME CHANGE: 20020918 FORMER COMPANY: FORMER CONFORMED NAME: CIGAR KING CORP DATE OF NAME CHANGE: 19990127 8-K 1 form_8-k.htm FORM 8-K FOR 05-12-2016


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report: May 12, 2016


    VISUALANT, INCORPORATED    

(Exact name of Registrant as specified in its charter)


    Nevada    

    0-25541    

    90-0273142    

(State or jurisdiction of incorporation)

(Commission File No.)

(IRS Employer Identification No.)


500 Union Street, Suite 420

Seattle, Washington 98101

                (206) 903-1351                

(Address of Registrant’s principal executive office and telephone number)




Section 8 – Other Events


Item 8.01 Other Events.


Issuance of Tenth Patent on its ChromaID™ technology


On May 12, 2016, Visualant, Incorporated (the “Company”), a provider of disruptive light-based technologies, announced that it had received its tenth patent relating to its ChromaID™ technology.


The newly issued patent describes an enhancement of the foundational ChromaID technology through its unique use of an array of variable wavelength LED emitters and photodiode detectors to measure the scattering of electromagnetic energy from a solid, fluid or a gas.


Visualant ChromaID is an identification, authentication and diagnostic platform technology that provides for a wide variety of real-time and real world applications.  They include, but are not limited to:


Determining if water is potable

Detecting explosive residue

Authenticating driver’s licenses, passports and access control cards

Detecting illegal drugs

Grading and certifying diamonds and other gem stones

Checking for counterfeit fluids including olive oil, wine and spirits

Confirming that the correct fluid is flowing through the IV drip line

Determining the butterfat content of milk


The patent issued by the United States Office of Patents and Trademarks is US Patent No. 9,316,581 B2 and is entitled “Method, Apparatus, and Article to Facilitate Evaluation of Substances Using Electromagnetic Energy.”


Item 9.01 Financial Statements and Exhibits.


(d)     Exhibits –


Exhibit No.

Description

 

 

99.1

Press Release of Visualant, Inc. dated May 12, 2016 related to the ninth patent award for the ChromaID™ technology.



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

Registrant: VISUALANT, INCORPORATED

 

 

 

 

By:

/s/ Ronald P. Erickson

 

 

Ronald P. Erickson CEO


May 12, 2016



EX-99 2 ex_99-1.htm PRESS RELEASE DATED 05-12-2016

Exhibit 99.1


Visualant Granted Tenth Patent


Continued Expansion of the ChromaID Intellectual Property Portfolio


Seattle, WA. – (May 12, 2016) Visualant, Inc. (OTCQB: VSUL) – an industry-leading provider of chromatic-based identification, authentication and diagnostic solutions, announced today that it has received its tenth patent relating to its ChromaID™ technology.


The newly issued patent describes an enhancement of the foundational ChromaID technology through its unique use of an array of variable wavelength LED emitters and photodiode detectors to measure the scattering of electromagnetic energy from a solid, fluid or a gas.


Visualant ChromaID is an identification, authentication and diagnostic platform technology that provides for a wide variety of real-time and real world applications.  They include, but are not limited to:


Determining if water is potable

Detecting explosive residue

Authenticating driver’s licenses, passports and access control cards

Detecting illegal drugs

Grading and certifying diamonds and other gem stones

Checking for counterfeit fluids including olive oil, wine and spirits

Confirming that the correct fluid is flowing through the IV drip line

Determining the butterfat content of milk


The patent issued by the United States Office of Patents and Trademarks is US Patent No. 9,316,581 B2 and is entitled “Method, Apparatus, and Article to Facilitate Evaluation of Substances Using Electromagnetic Energy.”


This newly issued patent continues the growth of the Visualant intellectual property portfolio.  The Company continues to have a significant number of pending patents and aggressively works to expand the reach of its technology.  Visualant’s ChromaID technology was invented when Dr. Thomas Furness, known as the “Father of Virtual Reality,” and a professor at the University of Washington, recognized that most materials in nature exhibit a unique light signature when stimulated by visible and invisible structured coherent light sources.


About Visualant, Inc.


Visualant™ is a public company whose shares trade under the stock symbol “VSUL.” The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can be used to identify, detect, or diagnose markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests. For more information on Visualant, visit the company’s website at www.visualant.net.


Visualant Press Contacts:


Hal Bringman

Email

hal@nvpr.com

Desk

+1 (206) 299-0622 ext 801

Mobile

+1 (310) 210-8011, Skype halbringman



GRAPHIC 3 visualant_logo.jpg GRAPHIC begin 644 visualant_logo.jpg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